Ridgecrest Capital Partners
Ridgecrest Capital Partners is a boutique investment banking firm headquartered in San Francisco and founded in 2001. Its public materials emphasize M&A advisory, private capital raising, technology-related markets, and emerging-growth companies.
What stands out about Ridgecrest Capital Partners
Ridgecrest publicly describes M&A advisory, capital raising, private equity and debt placements, restructurings and recapitalizations, and strategic-alternatives review services. Its publications focus on technology-related and emerging-growth sectors, including communications technology, mobile and wireless, software, online services, and cannabis emerging markets.[1][2][3]
What does Ridgecrest Capital Partners do?
Ridgecrest Capital Partners Incorporated is a boutique investment banking firm headquartered in San Francisco, California, founded in 2001, and identifying ridgecrestcap.com as its website.
Ridgecrest’s official company page characterizes the firm as privately held and operating in investment banking. Its public materials describe advisory and capital-raising services for technology-related and emerging-growth markets.[1][2]
Ridgecrest publicly states that it provides mergers and acquisitions advisory, capital raising, private equity and debt placements, restructurings and recapitalizations, and strategic-alternatives review services.
A Ridgecrest-hosted June 2018 publication describes the firm’s activity as M&A advisory and private capital raising for emerging growth companies.[1][2]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Ridgecrest Capital Partners?
An owner evaluating Ridgecrest should distinguish between the firm’s stated advisory capabilities and the market transactions described in its publications. The June 2018 publication does not identify which cannabis M&A transactions were directly advised by Ridgecrest, so direct attribution should be confirmed.
Commercial diligence should also address fees, minimum fees, engagement duration, tail provisions, client-size criteria, and the regulatory structure applicable to a proposed engagement. The official company page and Ridgecrest-hosted publications do not establish all of these points.[1][2][3]
Which recent transactions were directly advised by Ridgecrest, including any transactions listed in the June 2018 cannabis M&A publication
What are Ridgecrest's current sector, geography, revenue, EBITDA, enterprise-value, and transaction-size criteria for advisory engagements
What are the proposed fee, retainer, success-fee, expense, tail, exclusivity, and termination terms
What size transactions and clients does Ridgecrest Capital Partners focus on?
Ridgecrest’s public publications focus on technology-related markets, including communications technology, mobile and wireless, software, online services, and cannabis emerging markets.
Ridgecrest also published a dedicated Cannabis Emerging Markets Newsletter covering private financings, M&A transactions, and public-market activity.[2][3]
A Ridgecrest-hosted June 2018 publication lists Aurora Cannabis’ announced acquisition of MedReleaf on May 14, 2018 at an enterprise value of $1,970.2 million; Aurora Cannabis’ announced acquisition of CanniMed Therapeutics on May 1, 2018 at an enterprise value of $1,054.4 million; and Canopy Growth’s announced acquisition of Mettrum on January 31, 2017 at an enterprise value of $418.2 million.
These examples are presented as market transactions in the publication. The publication does not identify which transactions in its cannabis M&A tables were directly advised by Ridgecrest.[2]
Ridgecrest’s stated transaction services include M&A advisory, capital raising, private equity and debt placements, restructurings, recapitalizations, and strategic-alternatives reviews.
Its Ridgecrest-hosted 2015 Mobile & Wireless Newsletter contains sections for M&A transactions, private financings, public offerings, public-company valuations, and selected recent transactions.[1][3]
What does Ridgecrest Capital Partners publicly disclose about fees, process and engagement terms?
The official company page does not state Ridgecrest’s transaction fees, minimum fees, engagement-duration terms, tail provisions, or client-size thresholds.
The Ridgecrest-hosted June 2018 publication does not identify which of the market transactions in its cannabis M&A tables were directly advised by Ridgecrest. The Ridgecrest-hosted 2015 Mobile & Wireless Newsletter does not state a current universal revenue, EBITDA, enterprise-value, or transaction-size criterion for advisory engagements.
The official company page does not establish a firm-level broker-dealer registration, investment-adviser registration, securities registration, or other regulatory authorization.[1][2][3]
Ridgecrest’s official company page characterizes the firm as privately held and operating in investment banking.
The official company page does not establish a firm-level broker-dealer registration, investment-adviser registration, securities registration, or other regulatory authorization.[1]
The sources cited for this profile describe Ridgecrest’s M&A advisory, capital-raising, placement, restructuring, recapitalization, and strategic-alternatives services. They do not establish a standardized engagement process.[1][2]
Questions to ask before hiring Ridgecrest Capital Partners
Which recent transactions were directly advised by Ridgecrest, including any transactions listed in the June 2018 cannabis M&A publication?
What are Ridgecrest's current sector, geography, revenue, EBITDA, enterprise-value, and transaction-size criteria for advisory engagements?
What are the proposed fee, retainer, success-fee, expense, tail, exclusivity, and termination terms?
Which legal entity would enter into the engagement, and what regulatory registrations, broker-dealer affiliations, or exemptions apply?
Which senior professionals would lead the engagement and what buyer, investor, and lender relationships are currently active?
Sources & research notes
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.